111 related articles for article (PubMed ID: 26914246)
21. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
22. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
23. [STAT5 phosphorylation in CD34(+)CD38(-)CD123(+) bone marrow cells of the patients with myelodysplastic syndrome].
Liu BN; Fu R; Wang HQ; Li LJ; Yue LZ; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Xing LM; Guan J; Wang J; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):480-3. PubMed ID: 22967386
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U
Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789
[TBL] [Abstract][Full Text] [Related]
25. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
26. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
[TBL] [Abstract][Full Text] [Related]
27. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
[TBL] [Abstract][Full Text] [Related]
28. Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
Narukawa K; Masuda A; Takahashi T
Int J Hematol; 2021 Jun; 113(6):775-776. PubMed ID: 33864622
[No Abstract] [Full Text] [Related]
29. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
[TBL] [Abstract][Full Text] [Related]
30. [TfR2 mRNA expression in bone marrow mononuclear cells of children with hyperplastic anemia and its implications].
Chen TT; Yuan LX; Pan LL; Ma ZG; Gu L; Zhu YP; Gao J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):439-43. PubMed ID: 21518504
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders.
Yoon SY; Li CY; Lloyd RV; Tefferi A
Int J Hematol; 2000 Oct; 72(3):337-42. PubMed ID: 11185990
[TBL] [Abstract][Full Text] [Related]
32. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
Gu S; Song X; Zhao Y; Guo J; Fei C; Xu F; Wu L; Zhang X; Zhao J; Chang C; Li X
Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor k B is activated in myelodysplastic bone marrow cells.
Sanz C; Richard C; Prosper F; Fernandez-Luna JL
Haematologica; 2002 Sep; 87(9):1005-6. PubMed ID: 12217815
[TBL] [Abstract][Full Text] [Related]
34. Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: a hypothesis supported by unique case reports.
Valent P
Leuk Res; 2008 Sep; 32(9):1333-7. PubMed ID: 18417212
[TBL] [Abstract][Full Text] [Related]
35. The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency.
Kuiper-Kramer PA; Huisman CM; Van der Molen-Sinke J; Abbes A; Van Eijk HG
Acta Haematol; 1997; 97(3):127-31. PubMed ID: 9066706
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia.
Della Porta MG; Picone C; Tenore A; Yokose N; Malcovati L; Cazzola M; Ogata K
Haematologica; 2014 Jan; 99(1):e8-10. PubMed ID: 24425693
[No Abstract] [Full Text] [Related]
37. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V
Clin Cancer Res; 2012 Jun; 18(11):3079-89. PubMed ID: 22496271
[TBL] [Abstract][Full Text] [Related]
38. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
[TBL] [Abstract][Full Text] [Related]
39. Individual hematopoietic stem cells in human bone marrow of patients with aplastic anemia or myelodysplastic syndrome stably give rise to limited cell lineages.
Katagiri T; Kawamoto H; Nakakuki T; Ishiyama K; Okada-Hatakeyama M; Ohtake S; Seiki Y; Hosokawa K; Nakao S
Stem Cells; 2013 Mar; 31(3):536-46. PubMed ID: 23316019
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathology of myelodysplastic syndromes: biology of medullary stromal and hematopoietic cells (review).
Kitagawa M; Kurata M; Yamamoto K; Abe S; Suzuki S; Umeda S
Mol Med Rep; 2011; 4(4):591-6. PubMed ID: 21584497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
